XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
License revenue   $ 662,715   $ 662,715
Operating expenses:        
Research and development $ 697,723 1,737,039 $ 4,483,372 3,637,942
General and administrative 2,126,918 2,629,187 3,993,958 4,296,011
Restructuring costs 1,236,172   1,236,172  
Total operating expenses 4,060,813 4,366,226 9,713,502 7,933,953
Loss from operations (4,060,813) (3,703,511) (9,713,502) (7,271,238)
Other income (loss):        
Interest income, net 167,311 30,615 309,307 66,711
(Loss) gain on foreign currency transactions (135,659) 629,501 (197,394) 349,464
Research and development incentive award 478,959 306,233 478,959 306,233
Gain on fair value adjustments 5,379,500 805,422 1,010,631 3,680,116
Total other income 5,890,111 1,771,771 1,601,503 4,402,524
Income (loss) before income taxes 1,829,298 (1,931,740) (8,111,999) (2,868,714)
Income tax benefit (expense) 34,794 (11,609) 69,587 120,578
Net income (loss) 1,864,092 (1,943,349) (8,042,412) (2,748,136)
Other comprehensive income (loss)        
Unrealized gain (loss) on foreign currency translation 570,580 (1,288,433) 619,801 (703,052)
Total other comprehensive income (loss) 570,580 (1,288,433) 619,801 (703,052)
Total comprehensive income (loss) $ 2,434,672 $ (3,231,782) $ (7,422,611) $ (3,451,188)
Net income (loss) per share - basic $ 0.41 $ (1.23) $ (2.37) $ (1.91)
Weighted-average common shares outstanding - basic 4,536,235 1,575,244 3,391,151 1,437,654
Net income (loss) per share - diluted $ (0.77) $ (1.79) $ (2.66) $ (4.59)
Weighted-average common shares outstanding - diluted 4,536,235 1,575,244 3,391,151 1,437,654